Form 4: Envoy Medical Insider Converts Preferred Stock to Common, Distributes Shares

Anzu SPAC GP I LLC converted preferred stock to common stock in Envoy Medical and distributed shares to its members.

Summary

• Anzu SPAC GP I LLC, a significant shareholder in Envoy Medical, converted 373,333 shares of Series A Preferred Stock into 1,028,986 shares of Class A Common Stock on December 20, 2024.
• The conversion was based on a temporary reduction in the conversion price from $11.50 to $3.63 per share, effective from December 20, 2024, to January 20, 2025.
• Following the conversion, Anzu SPAC GP I LLC distributed 2,028,986 shares of Class A Common Stock to its members on December 23, 2024, for no consideration.
• Dr. Whitney Haring-Smith, who shares voting and investment control over the shares held by Anzu SPAC GP I LLC, is also listed as a reporting person.
• The preferred stock conversion was triggered by a voluntary, temporary reduction in the conversion price.

Sentiment

Score: 5

Explanation: The document reflects a standard post-SPAC transaction, with both positive and negative implications. The temporary reduction in conversion price is a slight concern, but overall the transaction is not unexpected.

Positives

• The conversion of preferred stock to common stock simplifies the capital structure of Envoy Medical.
• The distribution of shares to members of Anzu SPAC GP I LLC could increase the liquidity of the stock.

Negatives

• The temporary reduction in the conversion price could be seen as dilutive to existing shareholders.
• The distribution of a large number of shares could put downward pressure on the stock price.

Risks

• The temporary reduction in conversion price could be a sign of financial challenges.
• The large distribution of shares could lead to increased volatility in the stock price.
• The conversion and distribution could be perceived negatively by the market.

Management Comments

• Dr. Whitney Haring-Smith disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.

Industry Context

This type of transaction is common for companies that have recently gone public via a SPAC merger, where early investors often hold preferred stock that converts to common stock.

Comparison to Industry Standards

• The conversion of preferred stock to common stock is a standard practice in post-SPAC transactions, similar to what has been seen with other companies such as Lucid Motors and DraftKings.
• The temporary reduction in conversion price is less common and may indicate a need to incentivize conversion or a potential concern about the company's valuation.
• The distribution of shares to members of the sponsor group is also a typical step in the post-SPAC process, similar to what was seen with companies like Virgin Galactic.

Stakeholder Impact

• Shareholders may experience dilution due to the increased number of common shares.
• Members of Anzu SPAC GP I LLC will receive shares of Envoy Medical.
• The market may react to the increased number of shares and the temporary reduction in conversion price.

Key Dates

Keywords

preferred stock, common stock, conversion, Anzu SPAC GP I LLC, share distribution, Envoy Medical, insider trading, beneficial ownership